<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02660541</url>
  </required_header>
  <id_info>
    <org_study_id>BTF15-KR-401</org_study_id>
    <nct_id>NCT02660541</nct_id>
  </id_info>
  <brief_title>Burn Wound Management of Betafoam® and Allevyn® Ag</brief_title>
  <official_title>A Pilot Study to Compare Efficacy of Allevyn® Silver Dressing and Betafoam® in Patients With Wound of Acute Burn Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mundipharma Korea Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mundipharma Korea Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, controlled, multi-centre, open-label study.

      A total of 40 patients will be enrolled in this study. Patients will be randomly assigned to
      Betafoam® or Allevyn® Silver dressing for burn wounds after acute burn injury.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 21, 2016</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">February 28, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison between Betafoam® and Allevyn® Silver dressing, measured by days needed for complete re-epithelialization in burn wounds</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety assessed by documentation of adverse events, clinical laboratory results and vital signs</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Acute Burn</condition>
  <arm_group>
    <arm_group_label>Betafoam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brand name: Betafoam® This is a medicated device (dressing) consisting of 3% povidone iodine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Allevyn Silver dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brand name: Allevyn® Silver</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Betafoam</intervention_name>
    <description>Comparison between 2 medical devices</description>
    <arm_group_label>Betafoam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Allevyn Silver Dressing</intervention_name>
    <description>Comparison between 2 medical devices</description>
    <arm_group_label>Allevyn Silver dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adults ≥ 19 years

          2. Subjects of second-degree burn who have acute partial thickness burn (superficial to
             deep partial thickness) via investigator's visible assessment

          3. Burn total body surface area of &lt;15% range based on Lund and Browder chart presenting
             at the emergency room within the first 3~5 days post-injury will be considered for
             inclusion in this study.

             (If more than one burn wound is present that meets the inclusion criteria, the largest
             one among wounds that size are between 10x10 ㎝ and 20x20㎝ will be preferred to select
             as the Target wound.)

          4. Subjects who voluntarily sign the informed consent form

        Exclusion Criteria:

          1. Pregnant &amp; lactating females

          2. Known allergy to the dressing product including PVP-I

          3. Known hyperthyroidism or other acute thyroid diseases

          4. Subject with clinical infection who should be administered antibiotics continuously
             after enrolment

          5. Subject has any condition(s) that seriously compromises the patient's ability to
             complete this study.

          6. Subject has participated in interventional study utilizing an investigational drug
             within the previous 30 days

          7. Subject has one or more medical condition(s), diabetes, including renal, hepatic,
             hematologic, neurologic, or immune disease that presumably to hinder the wound healing
             processes by the physician's judgement.

          8. Subjects who are immune suppressed states, under chemo- or radiotherapy.

          9. The surgeon decides that surgery is necessary or requiring skin grafting.

         10. Burn injury sites at the ends of extremities and genitalia

         11. Burn injury caused of electronic burn

         12. Subjects who have inhaled damage, severe head injury or fracture on burn wound

         13. Scintillation scan for the diagnosis of thyroid takes at intervals of 1 to 2 weeks
             when using this dressing

         14. Vulnerable subjects.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dohern Kim, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hangang Sacred Heart Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hallym University Hangang Sacred Heart Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>150719</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2016</study_first_submitted>
  <study_first_submitted_qc>January 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2016</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dressing for burn wounds</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

